Youtube
PDPL

Parenteral Drugs (India) L..

₹3.7

Score

60

Technically Neutral

Parenteral Drugs (India) Price Change Analysis

Parenteral Drugs (India) Key Statistics
  • P/E Ratio

    -0.1

  • PEG Ratio

    -0

  • Market Cap Cr

    11

  • Price to Book Ratio

    -275.3

  • EPS

    -40.8

  • Dividend

    0 ()

  • Relative Strength Index

    46.79

  • Money Flow Index

    37.47

  • MACD Signal

    0.06

  • Average True Range

    0.11

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Parenteral Drugs (India) Synopsis

NSE-Medical-Diversified

Parenteral Drugs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 12.17 Cr. and Equity Capital is Rs. 29.82 Cr. for the Year ended 31/03/2021. Parenteral Drugs (India) Ltd. is a Public Limited Listed company incorporated on 13/12/1983 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1983PLC126481 and registration number is 126481.
  • Market Cap

    11.03

  • Sales

    9.29

  • Shares in Float

    0.81

  • No of Funds

    6

  • Yield

  • Book Value

    -0.02

  • U/D Vol Ratio

    0.7

  • LTDebt/Equity

  • Alpha

    -0.25

  • Beta

    0.05

Parenteral Drugs (India) Ownership
Parenteral Drugs (India) Management

Parenteral Drugs (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Parenteral Drugs (India) Financials

Parenteral Drugs (India) Technicals

EMA & SMA

CURRENT PRICE

EMA

Parenteral Drugs (India) Resistance and Support

Parenteral Drugs (India) Delivery and Volume

Parenteral Drugs (India) Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Parenteral Drugs (India) share price is

Open Demat Account